Summit Corporation – Announces a Novel Alzheimer Drug Candidate – Data to be Presented at Major Global Alzheimer Conference; Target Price 7.8p Summit Corporation, the UK based drug discovery company using its innovative Seglin™ drug discovery platform to identify candidates for areas of high unmet clinical need ,has announced positive news, this time from its […]